These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33779208)

  • 1. Barriers and Facilitators to PrEP Initiation and Adherence Among Transgender and Gender Non-Binary Individuals in Southern California.
    Watson CW; Pasipanodya E; Savin MJ; Ellorin EE; Corado KC; Flynn RP; Opalo C; Lampley E; Henry BL; Blumenthal J; Bolan R; Morris S; Moore DJ
    AIDS Educ Prev; 2020 Dec; 32(6):472-485. PubMed ID: 33779208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco.
    Cahill SR; Keatley J; Wade Taylor S; Sevelius J; Elsesser SA; Geffen SR; Wang T; Mayer KH
    AIDS Care; 2020 May; 32(5):585-593. PubMed ID: 31482726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California.
    Ogunbajo A; Storholm ED; Ober AJ; Bogart LM; Reback CJ; Flynn R; Lyman P; Morris S
    AIDS Behav; 2021 Jul; 25(7):2301-2315. PubMed ID: 33515132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
    Sevelius JM; Keatley J; Calma N; Arnold E
    Glob Public Health; 2016; 11(7-8):1060-75. PubMed ID: 26963756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review.
    Dang M; Scheim AI; Teti M; Quinn KG; Zarwell M; Petroll AE; Horvath KJ; John SA
    AIDS Patient Care STDS; 2022 Jun; 36(6):236-248. PubMed ID: 35687813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Barriers and Facilitators of Pre-exposure Prophylaxis (PrEP) Among Transgender and Gender Diverse Adults in an Integrated Health Care System.
    Bruxvoort K; Portugal C; Munis M; Pak K; Hechter R
    AIDS Behav; 2023 Aug; 27(8):2579-2591. PubMed ID: 36650390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and motivators to pre-exposure prophylaxis uptake among Black and Latina transgender women in Los Angeles: perspectives of current PrEP users.
    Nieto O; Fehrenbacher AE; Cabral A; Landrian A; Brooks RA
    AIDS Care; 2021 Feb; 33(2):244-252. PubMed ID: 32449399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.
    Rael CT; Martinez M; Giguere R; Bockting W; MacCrate C; Mellman W; Valente P; Greene GJ; Sherman S; Footer KHA; D'Aquila RT; Carballo-Diéguez A
    AIDS Behav; 2018 Nov; 22(11):3627-3636. PubMed ID: 29589137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing PrEP Awareness and Interest Among Filipina Transgender Women.
    Restar AJ; Adia A; Cu-Uvin S; Operario D
    AIDS Educ Prev; 2020 Jun; 32(3):212-228. PubMed ID: 32749880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications for PrEP Uptake in Young Adults Experiencing Homelessness: A Mixed Methods Study.
    Santa Maria D; Gallardo KR; Narendorf S; Petering R; Barman-Adhikari A; Flash C; Hsu HT; Shelton J; Ferguson K; Bender K
    AIDS Educ Prev; 2019 Feb; 31(1):63-81. PubMed ID: 30742477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices.
    Sevelius JM; Deutsch MB; Grant R
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21105. PubMed ID: 27760683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis.
    Wood SM; Lee S; Barg FK; Castillo M; Dowshen N
    J Adolesc Health; 2017 May; 60(5):549-555. PubMed ID: 28132744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
    Klein A; Golub SA
    AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.
    Auerbach JD; Kinsky S; Brown G; Charles V
    AIDS Patient Care STDS; 2015 Feb; 29(2):102-10. PubMed ID: 25513954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and facilitators to uptake and persistence on prep among key populations in Southern Province, Zambia: a thematic analysis.
    Stoebenau K; Muchanga G; Ahmad SS; Bwalya C; Mwale M; Toussaint S; Maambo C; Peters CJ; Baumhart C; Mwango LK; Lavoie MC; Claassen CW
    BMC Public Health; 2024 Jun; 24(1):1617. PubMed ID: 38886691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
    Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
    AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color.
    Wood S; Gross R; Shea JA; Bauermeister JA; Franklin J; Petsis D; Swyryn M; Lalley-Chareczko L; Koenig HC; Dowshen N
    AIDS Behav; 2019 Oct; 23(10):2719-2729. PubMed ID: 30993479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
    Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.
    Krakower D; Ware N; Mitty JA; Maloney K; Mayer KH
    AIDS Behav; 2014 Sep; 18(9):1712-21. PubMed ID: 24965676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review.
    Pacífico de Carvalho N; Mendicino CCP; Cândido RCF; Alecrim DJD; Menezes de Pádua CA
    AIDS Care; 2019 Oct; 31(10):1234-1240. PubMed ID: 31043069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.